These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10817771)

  • 1. Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine.
    Jardinet D; Lefèbvre C; Depresseux G; Lambert M; Devogelaer JP; Houssiau FA
    Rheumatology (Oxford); 2000 Apr; 39(4):389-92. PubMed ID: 10817771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus.
    Kipen Y; Briganti E; Strauss B; Will R; Littlejohn G; Morand E
    J Rheumatol; 1999 Feb; 26(2):310-7. PubMed ID: 9972964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids.
    Li EK; Tam LS; Young RP; Ko GT; Li M; Lau EM
    Br J Rheumatol; 1998 Apr; 37(4):405-10. PubMed ID: 9619891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study.
    Ishida T; Yoshida S; Kimura Y; Fujiki Y; Kotani T; Takeuchi T; Makino S; Arawaka S
    Lupus; 2018 Sep; 27(10):1636-1643. PubMed ID: 29954283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus.
    Uaratanawong S; Deesomchok U; Hiransuttikul N; Uaratanawong S
    J Med Assoc Thai; 2004 Nov; 87(11):1374-9. PubMed ID: 15825716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trabecular and cortical bone loss in systemic lupus erythematosus.
    Houssiau FA; Lefebvre C; Depresseux G; Lambert M; Devogelaer JP; Nagant de Deuxchaisnes C
    Br J Rheumatol; 1996 Mar; 35(3):244-7. PubMed ID: 8620299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women.
    Pons F; Peris P; Guañabens N; Font J; Huguet M; Espinosa G; Ingelmo M; Muñoz-Gomez J; Setoain J
    Br J Rheumatol; 1995 Aug; 34(8):742-6. PubMed ID: 7551659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density in premenopausal women with systemic lupus erythematosus.
    Uaratanawong S; Deesomchoke U; Lertmaharit S; Uaratanawong S
    J Rheumatol; 2003 Nov; 30(11):2365-8. PubMed ID: 14677178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus.
    Formiga F; Moga I; Nolla JM; Pac M; Mitjavila F; Roig-Escofet D
    Ann Rheum Dis; 1995 Apr; 54(4):274-6. PubMed ID: 7763104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus.
    Mendoza-Pinto C; García-Carrasco M; Sandoval-Cruz H; Escárcega RO; Jiménez-Hernández M; Etchegaray-Morales I; Soto-Vega E; Muñoz-Guarneros M; López-Colombo A; Delezé-Hinojosa M; Cervera R
    Clin Rheumatol; 2009 Jan; 28(1):65-70. PubMed ID: 18670734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus.
    Jacobs J; Korswagen LA; Schilder AM; van Tuyl LH; Dijkmans BA; Lems WF; Voskuyl AE; Bultink IE
    Osteoporos Int; 2013 Jun; 24(6):1827-33. PubMed ID: 23052940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three year follow-up of body composition changes in pre-menopausal women with systemic lupus erythematosus.
    Kipen Y; Briganti EM; Strauss BJ; Littlejohn GO; Morand EF
    Rheumatology (Oxford); 1999 Jan; 38(1):59-65. PubMed ID: 10334684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low pre-pregnant body mass index is a risk factor for the decrease of postpartum bone mineral density in systemic lupus erythematosus patients received glucocorticoid therapy.
    Ishida T; Yuri H; Nakamura E; Isoda K; Wada Y; Kotani T; Takeuchi T
    Lupus; 2022 Jun; 31(7):848-854. PubMed ID: 35440212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus.
    Mok CC; Wong SN; Ma KM
    Rheumatology (Oxford); 2012 Mar; 51(3):468-75. PubMed ID: 22096013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus.
    Hartkamp A; Geenen R; Godaert GL; Bijl M; Bijlsma JW; Derksen RH
    Arthritis Rheum; 2004 Nov; 50(11):3591-5. PubMed ID: 15529389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density change in systemic lupus erythematosus: a 5-year followup study.
    Zhu TY; Griffith JF; Au SK; Tang XL; Kwok AW; Leung PC; Li EK; Tam LS
    J Rheumatol; 2014 Oct; 41(10):1990-7. PubMed ID: 24986848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Retrospective Analysis of Longitudinal Changes in Bone Mineral Density in Women with Systemic Lupus Erythematosus.
    Mendoza-Pinto C; García-Carrasco M; Juárez-Melchor D; Munguía-Realpozo P; Etchegaray-Morales I; Santiago-Martín N; Ayón-Aguilar J; Méndez-Martínez S
    Calcif Tissue Int; 2021 Oct; 109(4):363-371. PubMed ID: 33864471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density changes in women with systemic lupus erythematosus.
    Boyanov M; Robeva R; Popivanov P
    Clin Rheumatol; 2003 Oct; 22(4-5):318-23. PubMed ID: 14579164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial.
    Mok CC; Ying SK; Ma KM; Wong CK
    Lupus; 2013 Dec; 22(14):1470-8. PubMed ID: 24113197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.